Non-steroidal anti-inflammatory drugs; overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors

CJ Hawkey, Michael Langman

Research output: Contribution to journalArticle

150 Citations (Scopus)

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) are well recognised as causing peptic ulceration and ulcer complications. However, several critical issues, including the amount of both gastrointestinal and non-gastrointestinal disease affected by NSAIDs, their interaction with ancillary risk factors, and how to optimise management in subgroups, remain poorly understood. In this article, strategies for subgroups that take account of non-specific gastrointestinal risks, minimisation of residual risk, and the importance of non-gastrointestinal toxicity are suggested, and areas for research identified.
Original languageEnglish
Pages (from-to)600-608
Number of pages9
JournalGut
Volume52
Issue number4
DOIs
Publication statusPublished - 1 Apr 2003

Fingerprint

Dive into the research topics of 'Non-steroidal anti-inflammatory drugs; overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors'. Together they form a unique fingerprint.

Cite this